188 related articles for article (PubMed ID: 32734471)
21. Relationship between CCR5
Martínez-Bonet M; González-Serna A; Clemente MI; Morón-López S; Díaz L; Navarro M; Puertas MC; Leal M; Ruiz-Mateos E; Martinez-Picado J; Muñoz-Fernández MA
Clin Microbiol Infect; 2017 May; 23(5):318-324. PubMed ID: 28042001
[TBL] [Abstract][Full Text] [Related]
22. Ancient DNA Investigation of a Medieval German Cemetery Confirms Long-Term Stability of CCR5-Δ32 Allele Frequencies in Central Europe.
Bouwman A; Shved N; Akgül G; Rühli F; Warinner C
Hum Biol; 2017 Apr; 89(2):119-124. PubMed ID: 29299966
[TBL] [Abstract][Full Text] [Related]
23. Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons.
Hummel S; Schmidt D; Kremeyer B; Herrmann B; Oppermann M
Genes Immun; 2005 Jun; 6(4):371-4. PubMed ID: 15815693
[TBL] [Abstract][Full Text] [Related]
24. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
Galvani AP; Novembre J
Microbes Infect; 2005 Feb; 7(2):302-9. PubMed ID: 15715976
[TBL] [Abstract][Full Text] [Related]
25. More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection.
Lucotte G; Dieterlen F
Infect Genet Evol; 2003 Nov; 3(4):293-5. PubMed ID: 14636691
[TBL] [Abstract][Full Text] [Related]
26. Distribution of the mutated delta 32 allele of the CCR5 gene in a Sicilian population.
Sidoti A; D'Angelo R; Rinaldi C; De Luca G; Pino F; Salpietro C; Giunta DE; Saltalamacchia F; Amato A
Int J Immunogenet; 2005 Jun; 32(3):193-8. PubMed ID: 15932625
[TBL] [Abstract][Full Text] [Related]
27. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic expressions of CCR5-delta32/delta32 homozygosity.
Nguyêñ GT; Carrington M; Beeler JA; Dean M; Aledort LM; Blatt PM; Cohen AR; DiMichele D; Eyster ME; Kessler CM; Konkle B; Leissinger C; Luban N; O'Brien SJ; Goedert JJ; O'Brien TR
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):75-82. PubMed ID: 10534150
[TBL] [Abstract][Full Text] [Related]
29. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
30. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis.
Zhou TB; Jiang ZP; Zhou JF; Su N
Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769
[TBL] [Abstract][Full Text] [Related]
31. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
[TBL] [Abstract][Full Text] [Related]
33. Frequency of the CCR5-delta32 allele in Brazilian populations: A systematic literature review and meta-analysis.
Silva-Carvalho WH; de Moura RR; Coelho AV; Crovella S; Guimarães RL
Infect Genet Evol; 2016 Sep; 43():101-7. PubMed ID: 27208805
[TBL] [Abstract][Full Text] [Related]
34. The prevalence of CCR5-Δ32 mutation in a cohort of Saudi stem cell donors.
Alarifi M; Al-Amro F; Alalwan A; Al-Turki A; Fakhoury H; Atallah N; Al-Muallimi M; Al-Balwi M; Alzahrani M; Alaskar A; Hajeer A; Jawdat D
HLA; 2017 Nov; 90(5):292-294. PubMed ID: 28731615
[TBL] [Abstract][Full Text] [Related]
35. CCR5 genotype and HIV-1 infection in perinatally-exposed infants.
Mas A; Español T; Heredia A; Pedraza MA; Hernandez M; Caragol I; Fernando M; Bertran JM; Alcami J; Soriano V
J Infect; 1999 Jan; 38(1):9-11. PubMed ID: 10090498
[TBL] [Abstract][Full Text] [Related]
36. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
Song GG; Lee YH
Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
[TBL] [Abstract][Full Text] [Related]
37. Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection.
Parczewski M; Leszczyszyn-Pynka M; Kaczmarczyk M; Adler G; Binczak-Kuleta A; Loniewska B; Boron-Kaczmarska A; Ciechanowicz A
J Appl Genet; 2009; 50(2):159-66. PubMed ID: 19433914
[TBL] [Abstract][Full Text] [Related]
38. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
[TBL] [Abstract][Full Text] [Related]
39. The geographic spread of the CCR5 Delta32 HIV-resistance allele.
Novembre J; Galvani AP; Slatkin M
PLoS Biol; 2005 Nov; 3(11):e339. PubMed ID: 16216086
[TBL] [Abstract][Full Text] [Related]
40. CCR5 genotype and resistance to vertical transmission of HIV-1.
Philpott S; Burger H; Charbonneau T; Grimson R; Vermund SH; Visosky A; Nachman S; Kovacs A; Tropper P; Frey H; Weiser B
J Acquir Immune Defic Syndr; 1999 Jul; 21(3):189-93. PubMed ID: 10421241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
